Grifols (GRFS) Minority Interest (2009 - 2021)
Grifols (GRFS) posted Minority Interest of $2.1 billion for Q3 2020, up 12.03% quarter-over-quarter from $1.8 billion in Q1 2020, and up 255.46% year-on-year from $578.6 million in Q4 2019.
Grifols (GRFS) Minority Interest (2009 - 2021) Analysis & Trends
Grifols (GRFS) has reported Minority Interest for 11 consecutive years, with $2.1 billion the latest figure, recorded in Q3 2020.
- Minority Interest for Q3 2020 came in at $2.1 billion, up 255.46% year-over-year; the trailing twelve-month figure through Sep 2020 was $2.1 billion (up 255.46% YoY), and the FY2019 annual result was $2.2 billion, up 316.62% from the prior year.
- Minority Interest was $2.1 billion for Q3 2020 at Grifols, up from $1.8 billion in the prior quarter.
- Over five years, Minority Interest peaked at $2.2 billion in Q4 2019 and troughed at $2.7 million in Q3 2018.
- Average Minority Interest over 5 years is $605.3 million, with a median of $7.0 million recorded in 2016.
- Year-over-year, Minority Interest jumped 113473.51% in 2016 and declined 27.92% in 2018.
- Over 5 years, Minority Interest stood at $7.0 million in 2016, then decreased by 17.99% to $5.8 million in 2017, then jumped by 9245.75% to $537.7 million in 2018, then jumped by 316.62% to $2.2 billion in 2019, then dropped by 8.18% to $2.1 billion in 2020.
- Per Business Quant data, the three most recent Minority Interest figures were $2.1 billion in Q3 2020, $1.8 billion in Q1 2020, and $2.2 billion in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Grifols | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.35 Bn |
| Dec 31, 2020 | 1.92 Bn |
| Sep 30, 2020 | 2.06 Bn |
| Mar 31, 2020 | 1.84 Bn |
| Dec 31, 2019 | 2.24 Bn |
| Sep 30, 2019 | 578.62 Mn |
| Dec 31, 2018 | 537.65 Mn |
| Sep 30, 2018 | 2.73 Mn |
| Jun 30, 2018 | 4.59 Mn |
| Mar 31, 2018 | 584.68 Mn |
| Dec 31, 2017 | 5.75 Mn |
| Jun 30, 2017 | 6.36 Mn |
| Dec 31, 2016 | 7.01 Mn |
| Sep 30, 2016 | 4.51 Mn |
| Jun 30, 2016 | 4.69 Mn |
| Dec 31, 2015 | 5.69 Mn |
| Sep 30, 2015 | 5.15 Mn |
| Jun 30, 2015 | 4,126.60 |
| Mar 31, 2015 | 4.75 Mn |
| Dec 31, 2014 | 5.96 Mn |